How does that "life creation" promise affect anything with the topic of the post, which is the financial valuation of the company?
Does that increase the financial valuation of the company? Expose risks in the S-1 that they haven't properly accounted for?
I don't read many Anthropic blog posts, but usually it's about a model release, interpretability research, or similar, and I haven't seen any of this marketing that you have. That said, they did somehow spend $2B on sales in the last quarter, almost 10x what it was in the prior quarter, and I don't get exposed to advertising anywhere; is this something that's getting played on TV? Billboards? Somewhere else?
The topic of this subthread, which you replied to, was about the sheer absurdity of this statement: "This is in fact very similar to one of Anthropic's guiding principles: underpromise and overdeliver."
That's it. Whatever you're going on about with financial valuations and S-1 risk is completely irrelevant to what you were replying to, because I was not making any kind of claim about those.